Diabetes Research Institute's First Patient In Biohub Trial No Longer Requires Insulin Therapy

News   Sep 11, 2015

 
Diabetes Research Institute's First Patient In Biohub Trial No Longer Requires Insulin Therapy
 
 
 

RELATED ARTICLES

Pfizer to Organize for Future Growth

News

Pfizer Inc. announced it will organize the company into three businesses.

READ MORE

Immatics Enters into a Strategic Partnership with Genmab

News

Immatics and Genmab to combine proprietary technologies to create transformative bispecific therapies against novel, proprietary tumor targets.

READ MORE

Trained to Turn on Themselves: Using Cancer Cells to Kill Cancer

News

What if cancer cells could be re-engineered to turn against their own kind? A new study led by researchers at Brigham and Women's Hospital leverages the power of gene editing to take a critical step toward using cancer cells to kill cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy